Literature DB >> 29575691

Individual factors influencing the duration of untreated psychosis.

Lama Souaiby1,2, Claire Gauthier1,3,4, Mathilde Kazes1,3,4, Célia Mam-Lam-Fook1,3,4, Claire Daban1,3,4, Marion Plaze1,3,4, Raphaël Gaillard1,3,4, Marie-Odile Krebs1,3,4.   

Abstract

AIM: Duration of untreated psychosis (DUP), or the time between onset of psychosis and treatment initiation, is a prognostic factor of schizophrenia. However, few studies evaluated the relative influence of individual-related factors on this duration. The objective of this study was to evaluate the influence of socio-demographic, clinical and cannabis use on DUP.
METHODS: This study was part of a large prospective study in help-seeking individuals referred to our specialized early detection / intervention clinic in the Service Hospitalo-Universitaire of Sainte-Anne Hospital in Paris (ICAAR study). We explored 33 consecutive patients who crossed the CAARMS' threshold of psychosis. The DUP and cannabis consumption history were explored during the baseline comprehensive assessment using all available sources (direct interviews of patients, parents, practitioners). Correlations between socio-demographic, clinical and cannabis use, and DUP were studied. A multiple linear regression model was used to determine the variables that could significantly predict DUP.
RESULTS: When considered individually, none of the socio-demographic and disease characteristic factors was associated with DUP, with the exception of level of education. In the multivariate analysis, age at inclusion, negative symptoms and history of cannabis use significantly influenced DUP.
CONCLUSION: The determinants of DUP are multi-factorial and include individual centred factors, such as age, cannabis and negative symptoms. The identification of factors resulting in delayed access to care may promote the development of effective strategies to reduce DUP in early psychosis and target effective early intervention.
© 2018 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  first-episode psychosis; negative symptoms; prodromes; psychosis onset; substance use

Year:  2018        PMID: 29575691     DOI: 10.1111/eip.12562

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  2 in total

1.  Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis.

Authors:  Thomas A Pollak; Angela Vincent; Conrad Iyegbe; Ester Coutinho; Leslie Jacobson; Dan Rujescu; James Stone; Julie Jezequel; Veronique Rogemond; Stephane Jamain; Laurent Groc; Anthony David; Alice Egerton; Rene S Kahn; Jerome Honnorat; Paola Dazzan; Marion Leboyer; Philip McGuire
Journal:  Biol Psychiatry       Date:  2020-11-24       Impact factor: 12.810

2.  Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms.

Authors:  Valerio Ricci; Giovanni Martinotti; Franca Ceci; Stefania Chiappini; Francesco Di Carlo; Julius Burkauskas; Ottavia Susini; Debora Luciani; Diego Quattrone; Domenico De Berardis; Mauro Pettorruso; Giuseppe Maina; Massimo Di Giannantonio
Journal:  Int J Environ Res Public Health       Date:  2021-11-30       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.